Browse by Series:

Choosing Frontline and Second-line Therapy for NSCLC

Mark A. Socinski, MD
Published: Wednesday, May 17, 2017



Mark A. Socinski, MD, Florida Hospital Cancer Institute, discusses how to decide first-line therapy, second-line therapy, and beyond for patients with non–small cell lung cancer.
Slider Left
Slider Right


Mark A. Socinski, MD, Florida Hospital Cancer Institute, discusses how to decide first-line therapy, second-line therapy, and beyond for patients with non–small cell lung cancer.
View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Cancer Summaries and Commentaries™: Update from Chicago: Advances in the Treatment of Breast CancerJul 31, 20181.0
Community Practice Connections™: The Next Generation in Renal Cell Carcinoma Treatment: An Oncology Nursing Essentials WorkshopJul 31, 20181.5
Publication Bottom Border
Border Publication
x